Tara Symonds

Folkestone, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Development and content validity of the Functional Impacts of Narcolepsy Instrument: a novel patient-reported outcome measure for narcolepsy type 1 and type 2.

Development and content validity of the Functional Impacts of Narcolepsy Instrument: a novel patient-reported outcome measure for narcolepsy type 1 and type 2.

Journal: Sleep

Published: November 03, 2025

Walking Capacity in Children With Ataxia Telangiectasia From the Global Ataxia Telangiectasia Family Data Platform.

Walking Capacity in Children With Ataxia Telangiectasia From the Global Ataxia Telangiectasia Family Data Platform.

Journal: Annals of the Child Neurology Society

Published: July 10, 2025

Practical applications of gamification in patient-centered outcomes research and digital health, and its acceptance in clinical trials.

Practical applications of gamification in patient-centered outcomes research and digital health, and its acceptance in clinical trials.

Journal: Frontiers in digital health

Published: June 23, 2025

Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent Clostridioides difficile infection.

Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent Clostridioides difficile infection.

Journal: Therapeutic advances in gastroenterology

Published: June 05, 2025

The evaluation of clinical outcomes assessments and digital health technologies in clinical trials for obesity.

The evaluation of clinical outcomes assessments and digital health technologies in clinical trials for obesity.

Journal: Journal of patient-reported outcomes

Published: June 07, 2024

Development of a novel patient-reported outcome measure for disseminated coccidioidomycosis (valley fever).

Development of a novel patient-reported outcome measure for disseminated coccidioidomycosis (valley fever).

Journal: The Journal of antimicrobial chemotherapy

Published: June 04, 2024

Comparisons and correlations of 1-month recall vs 24-hour recall in patient-reported outcomes of an exploratory, phase 2b, randomized, double-blind, placebo-controlled clinical trial of sildenafil cream, 3.6% for the treatment of female sexual arousal disorder.

Comparisons and correlations of 1-month recall vs 24-hour recall in patient-reported outcomes of an exploratory, phase 2b, randomized, double-blind, placebo-controlled clinical trial of sildenafil cream, 3.6% for the treatment of female sexual arousal disorder.

Journal: The journal of sexual medicine

Published: April 09, 2024

Development and refinement of the Clinical Global Impression of Improvement for Non-seizure Symptoms measure in Dravet syndrome and Lennox-Gastaut syndrome.

Development and refinement of the Clinical Global Impression of Improvement for Non-seizure Symptoms measure in Dravet syndrome and Lennox-Gastaut syndrome.

Journal: Journal of patient-reported outcomes

Published: April 05, 2024

Measurement properties of the Inclusion Body Myositis Functional Rating Scale.

Measurement properties of the Inclusion Body Myositis Functional Rating Scale.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 19, 2024

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome.

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome.

Journal: Journal of comparative effectiveness research

Published: July 29, 2023

Validation of the novel Eosinophilic Esophagitis Impact Questionnaire.

Validation of the novel Eosinophilic Esophagitis Impact Questionnaire.

Journal: Journal of patient-reported outcomes

Published: July 03, 2023

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.

Journal: Scientific reports

Published: April 16, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026